Sector
PharmaceuticalsOpen
₹339.5Prev. Close
₹338.95Turnover(Lac.)
₹206.43Day's High
₹341.15Day's Low
₹322.352 Week's High
₹387.5552 Week's Low
₹190Book Value
₹121.18Face Value
₹2Mkt Cap (₹ Cr.)
2,984.68P/E
0EPS
0Divi. Yield
0.0614 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
30 Aug 2024
12:00 AM
AGM
Announcement Date: 30 Aug, 2024
16 May 2024
12:00 AM
Dividend
Dividend Amount: 1.5
Record Date: 19 Sep, 2024
The company has a strong foothold in the Indian pharma market as well as in the international market where it sells its products in more than 55 countries
Indoco Remedies stated that it will respond to the Form 483 observations within the prescribed timeline.
Here are some of the stocks that may see significant price movement today: IndusInd Bank, Hindustan Zinc, Thermax, etc.
Indoco Remedies will also continue providing products to its existing B2B customers under existing deals.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 18.44 | 18.43 | 18.43 | 18.43 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,108.18 | 1,008.59 | 885.87 | 750.5 |
Net Worth | 1,126.62 | 1,027.02 | 904.3 | 768.93 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Revenue | 1,240.3 | 1,105.99 | 967.73 | 1,038.21 |
yoy growth (%) | 12.14 | 14.28 | -6.78 | -5.1 |
Raw materials | -354.06 | -330.42 | -320.17 | -346.03 |
As % of sales | 28.54 | 29.87 | 33.08 | 33.32 |
Employee costs | -272.87 | -255.31 | -231.26 | -220.33 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 131.35 | 28.7 | -9.24 | 48.42 |
Depreciation | -73.12 | -70.81 | -71.56 | -67.7 |
Tax paid | -38.95 | -4.46 | 6.4 | -7.23 |
Working capital | 108.84 | 8.53 | -20.15 | -48.05 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2019 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 12.14 | 14.28 | -6.78 | -5.1 |
Op profit growth | 81.26 | 60.8 | -43.11 | -13.9 |
EBIT growth | 179.41 | 386.57 | -84.29 | -26.21 |
Net profit growth | 281.02 | -953.47 | -106.89 | -46.81 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 1,641.29 | 1,788.22 | 1,640.05 | 1,503.73 | 1,218.61 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,641.29 | 1,788.22 | 1,640.05 | 1,503.73 | 1,218.61 |
Other Operating Income | 23.63 | 29.07 | 28.56 | 37.02 | 22.92 |
Other Income | 6.44 | 21.38 | 2.34 | 2.33 | 3.12 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,703.4 | 95.58 | 4,08,666.73 | 2,000.46 | 0.94 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,790.5 | 81.57 | 1,80,131.05 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,482.4 | 24.88 | 1,19,745.08 | 1,485.4 | 1.08 | 4,254.47 | 397.39 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,504.6 | 62.68 | 1,18,597.8 | 474 | 0.17 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,639.3 | 57.84 | 1,08,985.15 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Suresh G Kare
Managing Director
Aditi Kare Panandikar
Joint Managing Director
Sundeep V Bambolkar
Independent Non Exe. Director
Vasudha V Kamat
Independent Non Exe. Director
Abhijit Y Gore
Non Executive Director
Anand Nadkarni
Independent Non Exe. Director
Ajay Mulgaokar
Independent Non Exe. Director
Satish Shenoy
Company Sec. & Compli. Officer
Ramanathan Hariharan
Indoco House 166 C S T Road,
Santacruz (East) Kalina,
Maharashtra - 400098
Tel: 91-022-26541851-55
Website: http://www.indoco.com
Email: compliance.officer@indoco.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Indoco Remedies Limited, incorporated on August 23, 1947 is a Mumbai-based pharmaceutical company focused on formulations, with some presence in contract manufacturing and research. The Company headqu...
Read More
Reports by Indoco Remedies Ltd
What is the Indoco Remedies Ltd share price today?
What is the Market Cap of Indoco Remedies Ltd?
What is the PE and PB ratio of Indoco Remedies Ltd?
What is the 52 Week High and Low of Indoco Remedies Ltd?
What is the CAGR of Indoco Remedies Ltd?
What is the shareholding pattern of Indoco Remedies Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
